Maximizing Outcomes: The Impact of Oral Medications on Weight Management
Disease State Management/Drug Therapy CE for Pharmacists
Monograph
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Want another way to take this test? Check out the video-based version of this course.
Course Summary
Oral anti-obesity medications (AOMs) serve as valuable tools in the management of obesity. Current guidelines advocate for a multimodal approach to obesity treatment, incorporating lifestyle interventions such as diet and exercise alongside pharmacotherapy when appropriate. The decision to initiate an oral AOM should be personalized, considering the weight loss goals, the comorbidities of the patient, and the safety profile of the medication. This educational activity will provide an in-depth review of the mechanisms of action, dosing strategies, and the efficacy and safety profiles of oral AOMs. Additionally, this activity will emphasize the critical role of long-term monitoring, shared decision-making, and interprofessional collaboration in ensuring these therapies are used safely and effectively to optimize patient outcomes.
Compare and Contrast the mechanisms of oral anti-obesity medications (AOMs) in weight management
Describe the efficacy and safety of oral AOMs
Identify interprofessional collaboration strategies to optimize treatment outcomes
Educate patients on the appropriate use of oral AOMs
Course Syllabus
I. Introduction
II. Mechanisms and Effectiveness of Oral AOMs
A. Orlistat
B. Phentermine
C. Phentermine-Topiramate
D. Naltrexone-Bupropion
III. Comparison of Anti-Obesity Drugs for Obesity Management
IV. Initiating and Stopping Oral AOMs
A. Initiating Oral AOMs
B. Evaluating Treatment Response and Stopping Rules
C. Discontinuating Oral AOMs and Managing Weight Regain
V. The Role of Collaborative Practice Models in Obesity Treatment
VI. Access, Affordability, and Adherence Challenges
VII. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in developing this activity: L. Austin Fredrickson, MD, FACP, Liz Fredrickson, PharmD, BCPS, Susan Bowlin, DNP, FNP-BC, ACNP-BC, CBN, and Pamela Sardo, PharmD, BS. Austin Frederickson, Liz Frederickson, and Pamela Sardo have no conflict of interest or financial relationship or commercial or financial support relevant to this activity to report or disclose in the development of this activity. Susan Bowlin is a member of the Speaker’s Bureau for Eli Lilly and Novo Nordisk. Any potential conflicts of interest were mitigated.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
- Target Audience: Pharmacist
- Secondary Audiences: This educational activity is also for other healthcare professionals, such as nurses, physicians, or others who may be part of a healthcare team and may be interested in this educational topic. A healthcare team approach to patient care may be discussed in this activity, as applicable. No state board or professional organization has evaluated this activity to determine whether it meets the continuing education requirements of nurses, physicians, or other professions not listed under the “Target Audience” described above. Always verify with individual employers or supervisors whether they will accept this educational activity upon completion.
- Contact Hours: 2.0 (0.2 CEUs)
- Activity Release Date: 4/21/2025
- Activity Expiration Date: 4/21/2028
- Activity Type: Knowledge
- UAN: 0669-0000-25-046-H01-P
- Topic: Disease State Management/Drug Therapy
- CeBroker Number: 20-1298519
Faculty:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.